Status: Recruiting
Domperidone in Treating Patients With Gastrointestinal Disorders
This phase III trial studies how well domperidone works in treating patients with gastrointestinal disorders. Domperidone may help control chronic gastrointestinal disorders and their symptoms, such as pain, bloating, and nausea and vomiting, by stimulating contraction of the stomach to increase its ability to empty itself of food.
Participants needed: 200
Trial details
Phase: Phase 3Age: 16+Biological sex: AllType: InterventionalSponsor: M.D. Anderson Cancer CenterUpdated: Apr 13, 2026Locations: 1
Eligibility criteria
Patients with GI disorders who have failed standard therapy [+13]
Patients with the following cardiac diagnoses: ventricular tachycardia or fibril... [+8]